Roche’s Alecensa adds the large EU market for non-small cell lung cancer treatment.
- Investopedia•2 days ago
Roche filed suit to fend off competition from Amgen’s biosimilar for its bestselling drug Avastin.
- Motley Fool•2 days ago
These drug kingpins are raking in the dough, which could lead to handsome returns for investors.
RHHBY : Summary for ROCHE HLDG LTD SPONS - Yahoo Finance
Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||30.31 - 30.57|
|52 Week Range||25.25 - 33.77|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.74|
|Dividend & Yield||1.02 (3.34%)|
|1y Target Est||N/A|